Cortex Pharmaceuticals, Inc.

Single Pharmaceutical-based Strategy Aims To Solve Neurological And Psychiatric Disorders

An emerging microcap firm out of Irvine, California is developing novel drug therapies for the treatment of neurological and psychiatric disorders.

Cortex Receives U.S. Patent for the Use of AMPAKINE Molecules to Treat Respiratory Depression

Cortex Pharmaceuticals, Inc. (OTCBB:CORX.ob) announced that it has received a Notice of Allowance from the U.S.

Cortex Enters into New Agreement with Servier

Cortex To Recieve Up To $3 Million If Servier Option Is Exercised.